Zubieta Rico, Pablo F. http://orcid.org/0000-0002-1211-4836
Schneider, Ludwig http://orcid.org/0000-0002-3910-8217
Pérez-Lemus, Gustavo R. http://orcid.org/0000-0002-8650-8467
Alessandri, Riccardo http://orcid.org/0000-0003-1948-5311
Dasetty, Siva http://orcid.org/0000-0002-1666-7980
Nguyen, Trung D. http://orcid.org/0000-0002-5076-264X
Menéndez, Cintia A. http://orcid.org/0000-0003-4085-5882
Wu, Yiheng http://orcid.org/0009-0001-0524-7251
Jin, Yezhi
Xu, Yinan http://orcid.org/0000-0002-5824-3502
Varner, Samuel http://orcid.org/0000-0002-1365-1027
Parker, John A. http://orcid.org/0000-0001-8157-2403
Ferguson, Andrew L. http://orcid.org/0000-0002-8829-9726
Whitmer, Jonathan K. http://orcid.org/0000-0003-0370-0873
de Pablo, Juan J. http://orcid.org/0000-0002-3526-516X
Article History
Received: 7 April 2023
Accepted: 12 December 2023
First Online: 14 February 2024
Competing interests
: A. L. F. is a co-founder and consultant of Evozyne, Inc. and a co-author of US Patent Applications 16/887,710 and 17/642,582, US Provisional Patent Applications 62/853,919, 62/900,420, 63/314,898, and 63/479,378 and International Patent Applications PCT/US2020/035206 and PCT/US2020/050466.